Correlation Between Gastrojejunal Anastomosis Diameter, Distensibility Index, and Weight Regain After Roux-en-Y Gastric Bypass.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 29 06 2023
accepted: 18 10 2023
revised: 17 10 2023
medline: 30 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Gastrojejunal anastomosis (GJA) dilation is an independent predictor of weight regain (WR) after Roux-en-Y gastric bypass (RYGB). However, the role of planimetric measurements in this context remains unknown. This is a retrospective cohort study including adult RYGB patients who underwent a diagnostic endoscopy with Endoflip assessment of the GJA. We excluded patients in the early postoperative period and those with abnormal endoscopic findings (marginal ulcers and gastro-gastric fistulas). Thirty-four patients were initially included. Endoscopic GJA diameter had a moderate positive correlation with WR (r=+0.438, p=0.011). However, after excluding the 7 patients with GJA> 30 mm, there was no significant correlation. There was a moderate agreement between the EndoFLIP-GJA diameter at 60mL and endoscopic diameter (ICC=0.576, p=0.049). The distensibility index (DI) showed a consistent moderate negative correlation with WR. Considering the maximum DI at 40 ml, we found a cutoff of DI = 7 mm Visual estimation of the GJA diameter correlates with EndoFLIP at 60mL. In the subset of patients with GJA ≤ 30 mm, more distensible GJAs are associated with lower rates of WR. Larger studies are needed to confirm this correlation and to validate its utility for clinical management.

Identifiants

pubmed: 37922061
doi: 10.1007/s11695-023-06918-3
pii: 10.1007/s11695-023-06918-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4042-4048

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Lopes EC et al. Is Bariatric Surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25(9):1741–9.
doi: 10.1007/s11695-015-1777-5 pubmed: 26112137
Surgery, A.S.f.M.a.B. Estimate of bariatric surgery numbers, 2011-2021. 2022; Available from: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers .
King WC, Hinerman AS, Courcoulas A. Weight regain after bariatric surgery: a systematic literature review and comparison across studies using a large reference sample. Surg Obes Relat Dis. 2020;16(8):1133–44.
doi: 10.1016/j.soard.2020.03.034 pubmed: 32446593
Sjöström L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
doi: 10.1056/NEJMoa066254 pubmed: 17715408
Abu Dayyeh BK, Lautz DB, Thompson CC. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2011;9(3):228–33.
doi: 10.1016/j.cgh.2010.11.004 pubmed: 21092760
Thompson CC et al. Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. Gastroenterology. 2013;145(1):129–137.e3.
doi: 10.1053/j.gastro.2013.04.002 pubmed: 23567348
Brunaldi VO et al. Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: back to stage 0? Endosc Int Open. 2023;11(5):E538–e545.
doi: 10.1055/a-2075-1198 pubmed: 37251791 pmcid: 10219785
Desprez C et al. The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP(®) ) in the gastrointestinal tract: a systematic review. Neurogastroenterol Motil. 2020;32(9):e13980.
doi: 10.1111/nmo.13980 pubmed: 32856765
Haq Z et al. The utility of EndoFLIP for measuring gastrojejunal anastomosis diameter and distensibility in patients experiencing weight regain post Roux-en-Y gastric bypass. Obes Surg. 2021;31(7):3353–9.
doi: 10.1007/s11695-021-05302-3 pubmed: 33646518
Kim EY. Definition, mechanisms and predictors of weight loss failure after bariatric surgery. J Metab Bariatr Surg. 2022;11(2):39–48.
doi: 10.17476/jmbs.2022.11.2.39 pubmed: 36926678
Thomas DD et al. Weight recidivism after Roux-en-Y gastric bypass surgery: an 11-year experience in a multiethnic medical center. Obesity (Silver Spring). 2019;27(2):217–25.
doi: 10.1002/oby.22360 pubmed: 30421862
Majid SF et al. Current state of the definition and terminology related to weight recurrence after metabolic surgery: review by the POWER Task Force of the American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(7):957–63.
doi: 10.1016/j.soard.2022.04.012 pubmed: 35680532
Heneghan HM et al. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis. 2012;8(4):408–15.
doi: 10.1016/j.soard.2011.09.010 pubmed: 22055390
Shariq OA et al. Impact of early gastrojejunal stenosis on weight loss in patients undergoing Roux-en-Y gastric bypass. Surg Laparosc Endosc Percutan Tech. 2023;33(2):202–6.
doi: 10.1097/SLE.0000000000001165 pubmed: 36971521
Jirapinyo P et al. Dose response for argon plasma coagulation in the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2020;91(5):1078–84.
doi: 10.1016/j.gie.2019.12.036 pubmed: 31904378 pmcid: 7183414
Tuma F et al. The inaccuracy of the endoscopic anastomotic measurement techniques. Ann Laparosc Endosc Surg. 2019;4:73.
Yadlapati R et al. Inter- and intra-rater agreement of interpretation of functional lumen imaging probe in healthy subjects. Neurogastroenterol Motil. 2023;35(3):e14505.
doi: 10.1111/nmo.14505 pubmed: 36480408
Snape WJ et al. Evaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomiting. Neurogastroenterol Motil. 2016;28(5):758–64.
doi: 10.1111/nmo.12772 pubmed: 26813266
Malik Z, Sankineni A, Parkman H. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis. Neurogastroenterol Motil. 2015;27(4):524–31.
doi: 10.1111/nmo.12522 pubmed: 25712043
Gourcerol G et al. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther. 2015;41(4):360–7.
doi: 10.1111/apt.13053 pubmed: 25523288
Brunaldi VO et al. Argon plasma coagulation alone versus argon plasma coagulation plus full-thickness endoscopic suturing to treat weight regain after Roux-en-Y gastric bypass: a prospective randomized trial (with videos). Gastrointest Endosc. 2020;92(1):97–107.e5.
doi: 10.1016/j.gie.2020.03.3757 pubmed: 32217111
Riccioppo D et al. Small-volume, fast-emptying gastric pouch leads to better long-term weight loss and food tolerance after Roux-en-Y gastric bypass. Obes Surg. 2018;28(3):693–701.
doi: 10.1007/s11695-017-2922-0 pubmed: 28913642
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.
doi: 10.1111/joim.12012 pubmed: 23163728

Auteurs

Farah Abdul Razzak (FA)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Anthony Kerbage (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Vitor O Brunaldi (VO)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.
Gastroenterology Department, University of Sao Paulo Medical School, Sao Paulo, Brazil.

Rudy Mrad (R)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Tala Mahmoud (T)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Khushboo Gala (K)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Eric J Vargas (EJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Andrew Storm (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA.

Omar Ghanem (O)

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Barham Abu Dayyeh (BA)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Rochester, MN, 55905, USA. abudayyeh.barham@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH